Remepy
PrivateLast Round
Seed
May 1, 2024
Total Funding Raised
$10M
Company Overview
Remepy is a health tech company that develops hybrid drugs, which combine traditional medications with digital therapeutic software to enhance treatment effectiveness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Patient Engagement, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remepy Comps
Public and private peers based on sector, stage, and business model.
Remepy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Remepy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vine Ventures | Seed |
| NFX | Seed |
| Fresh.Fund | Seed |
| Firstime | Seed |
| StageNext Fund | Seed |
| TechAviv | Seed |
| Supernode Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Collaborating with Merck KGaA on hybrid drugs combining pharmaceuticals and digital therapies.
- Feb 1, 2026
Added Bisy GmbH, an IT services and software development startup, as a customer.
Remepy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remepy's valuation, stock price, and market status.
